Pediatric Infectious Disease

Register      Login

VOLUME 4 , ISSUE 3 ( July-September, 2022 ) > List of Articles


Pseudomonas Urinary Tract Infection

Jeeson C Unni, Asima Chadupery, Kiran Raghu

Keywords : Pseudomonas aeruginosa, Urinary tract infection, Urinary tract infection prophylaxis

Citation Information : Unni JC, Chadupery A, Raghu K. Pseudomonas Urinary Tract Infection. Pediatr Inf Dis 2022; 4 (3):114-115.

DOI: 10.5005/jp-journals-10081-1369

License: CC BY-NC 4.0

Published Online: 31-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Pseudomonas aeruginosa is an opportunistic infectious agent, which is known to cause severe urinary tract infections (UTI) in children. As these organisms are intrinsically resistant to commonly used antibacterial and because new resistances develop while on treatment, infections caused by these organisms are difficult to treat. This case highlights the risk factors for the development of UTI by this organism, the need for periodic updation of local hospital antibiograms for this emerging infection, and suggests a revisit into recommendations for indications for invasive urinary tract procedures like micturating cystourethrogram (MCU) and UTI prophylaxis.

PDF Share
  1. Kaufman J, Temple-Smith M, Sanci L. Urinary tract infections in children: an overview of diagnosis and management. BMJ Paediatr Open 2019;3(1):e000487. DOI: 10.1136/bmjpo-2019-000487
  2. Beetz R, Westenfelder M. Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents 2011;38:42–50. DOI: 10.1016/j.ijantimicag.2011.09.006
  3. Balasubramanian S, Kuppuswamy D, Padmanabhan S, et al. Extended-spectrum beta-lactamase-producing community-acquired urinary tract infections in children: chart review of risk factors. J Glob Infect Dis 2018;10(4):222–225. DOI: 10.4103/0974-777X.246391
  4. Marcus N, Ashkenazi S, Samra Z, et al. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Infection 2008;36(5):421–426. DOI: 10.1007/s15010-008-7328-4
  5. Balighian E, Burke M. Urinary tract infections in children. Pediatr Rev 2018;39(1):3–12. DOI: 10.1542/pir.2017-0007
  6. Bitsori M, Maraki S, Koukouraki S, et al. Pseudomonas aeruginosa urinary tract infection in children: risk factors and outcomes. J Urol 2012;187(1): 260–264. DOI: 10.1016/j.juro.2011.09.035
  7. Goldman M, Rosenfeld-Yehoshua N, Lerner-Geva L, et al. Clinical features of community-acquired Pseudomonas aeruginosa urinary tract infections in children. Pediatr Nephrol 2008;23(5):765–768. DOI: 10.1007/s00467-007-0697-6
  8. Ozumba UC. Urinary tract infections in children due to Pseudomonas aeruginosa in Enugu Nigeria. J Trop Pediatr 1998;44(5):315–316. DOI: 10.1093/tropej/44.5.315
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.